Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 47N3Y | — |
administered just the diluent of Shingrix without the powder; administered just the diluent of Shingrix without the powder; This non-serious case was reported by a physician via sales rep and described the occurrence of inappropriate preparation of medication in a 92-year-old female patient who received Herpes zoster (Shingrix) (batch number 47N3Y, expiry date 30-MAR-2027) for prophylaxis. On 12-SEP-2025, the patient received Shingrix. On 12-SEP-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: administered just the diluent of Shingrix without the powder) and inappropriate dose of vaccine administered (Verbatim: administered just the diluent of Shingrix without the powder). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable.